Last reviewed · How we verify

NCT05306639

Treatment of Monosymptomatic Nocturnal Enuresis

Status unknown NA Last updated 12 January 2023
What this trial tests

NA trial testing Rehabilitation in Nocturnal Enuresis in 40 participants. Status unknown.

Timeline
1 February 2023
Primary endpoint
1 June 2023
1 July 2023

Quick facts

Lead sponsorUniversity of Alexandria
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 February 2023
Primary completion1 June 2023
Estimated completion1 July 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

University of Alexandria

Who can join

Adults 5 to 30, any sex, with Nocturnal Enuresis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective randomized trial to study the effect of spinal magnetic stimulation versus posterior tibial neuromodulation in the treatment of monosymptomatic nocturnal enuresis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Rehabilitation

Trials testing the same drug.

Other recruiting trials for Nocturnal Enuresis

Currently open trials in the same condition.

Other University of Alexandria trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05306639.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing